SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination

Many safe and effective severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccinations dramatically reduce risks of coronavirus disease 2019 (COVID‐19) complications and deaths. We aimed to describe cases of SARS‐CoV‐2 infection among patients with chronic liver disease (CLD) and liver tr...

Full description

Bibliographic Details
Main Authors:	Andrew M. Moon, Gwilym J. Webb, Ignacio García‐Juárez, Anand V. Kulkarni, Gupse Adali, David K. Wong, Beth Lusina, George N. Dalekos, Steven Masson, Brandon M. Shore, Eleanor Barnes, A. Sidney Barritt IV, Thomas Marjot
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-04-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1853

Similar Items

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
by: Luke Baldelli, et al.
Published: (2023-01-01)

Determining risk factors for mortality in liver transplant patients with COVID-19
by: Webb, GJ, et al.
Published: (2020)

Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls
by: Pablo Serrano Rodriguez, et al.
Published: (2018-01-01)

Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma
by: Gupse Adali, et al.
Published: (2024-09-01)

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
by: Webb, GJ, et al.
Published: (2020)

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
by: Tingyan Wang, et al.
Published: (2021-09-01)

Circadian rhythm and misalignment in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD): an experimental medicine approach
by: Marjot, T
Published: (2023)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
by: Moon, AM, et al.
Published: (2020)

Non-alcoholic fatty liver disease and diabetes.
by: Hazlehurst, J, et al.
Published: (2016)

Liver transplantation for late-onset presentations of acute liver failure in Wilson's disease: The UK experience over 2 decades
by: Samuel Shribman, et al.
Published: (2020-06-01)

FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases
by: Kalliopi Zachou, et al.
Published: (2021-05-01)

Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers
by: Wang, T, et al.
Published: (2021)

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
by: Marjot, T, et al.
Published: (2020)

Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
by: Marjot, T, et al.
Published: (2019)

Condition of the liver’s liver of rats, received a high-fat diet: biochemical indicators
by: V. L. Vasyuk, et al.
Published: (2017-01-01)

Condition of the liver’s liver of rats, received a high-fat diet: biochemical indicators
by: V. L. Vasyuk, et al.
Published: (2017-01-01)

TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species
by: Eunus S. Ali, et al.
Published: (2021-08-01)

Emergency Liver Resection with Staplers for Spontaneous Liver Haemorrhage in a Patient Receiving Anticoagulant Therapy
by: Koray Kutlutürk, et al.
Published: (2013-01-01)

Renal and liver impairment in patients receiving cytotoxic chemotherapy
by: Nungrutai Saeaib, et al.
Published: (2010-02-01)

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
by: Anand V. Kulkarni, et al.
Published: (2023-06-01)

Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisationResearch in context
by: William Bernal, et al.
Published: (2024-11-01)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
by: Rakesh Kumar Jagdish, et al.
Published: (2023-06-01)

Outcomes of adults who received liver transplant as young children
by: Sunitha Vimalesvaran, et al.
Published: (2021-08-01)

The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
by: Moon Young Kim
Published: (2017-06-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

Metabolic syndrome frequency in inflammatory bowel diseases
by: Elif Yorulmaz, et al.
Published: (2011-01-01)

Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study
by: Alfredo Caturano, et al.
Published: (2023-10-01)

Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
by: Amalia Pelegrina, et al.
Published: (2017-12-01)

Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT
by: Peerapat Thanapongsatorn, et al.
Published: (2022-02-01)

A new organ preservation solution for static cold storage of the liver. Amniotic fluid
by: Başak Büyük, et al.
Published: (2019-04-01)

Alcohol-related liver disease and liver transplantation
by: Musheer Shafqat, et al.
Published: (2022-06-01)

Is iron overload associated with worse outcomes in patients with chronic liver disease undergoing liver transplantation?
by: Sergio Rodriguez-Rodriguez, et al.
Published: (2024-01-01)

Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
by: Ying Feng, et al.
Published: (2023-02-01)

Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019
by: Sonia Wang, et al.
Published: (2020-01-01)

Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
by: Sonia Wang, et al.
Published: (2020-01-01)

Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity
by: Mozes, F, et al.
Published: (2018)

SARS-CoV-2 infection in patients with autoimmune hepatitis
by: Marjot, T, et al.
Published: (2021)

Decreased serum DNase1-activity in patients with autoimmune liver diseases
by: Nikolaos K. Gatselis, et al.
Published: (2017-02-01)

Journey of Natural Killer Cells and their Role in Liver Diseases
by: Archana Buch, et al.
Published: (2022-04-01)